T1	p 94 119	chronic periodontitis : a
T2	p 376 377	)
T3	p 388 453	Twenty-four patients presenting with ?12 teeth with probing depth
T4	p 483 490	probing
T5	p 591 598	control
T6	p 616 631	pockets with PD
T7	p 682 695	teeth with PD
T8	p 779 798	all pockets with PD
T9	p 1959 1982	chronic periodontitis .
T10	i 68 81	chlorhexidine
T11	i 231 258	chlorhexidine ( CHX ) chips
T12	i 357 377	root planing ( SRP )
T13	i 553 600	CHX chips ( test ) or placebo chips ( control )
T14	i 655 660	, SRP
T15	i 714 727	appointment .
T16	i 746 755	SRP , new
T17	i 859 864	SRP ;
T18	i 969 974	SRP ;
T19	i 1008 1045	Periodontal pathogens Aggregatibacter
T20	i 1121 1131	Tannerella
T21	i 1142 1143	,
T22	i 1642 1655	placebo group
T23	i 1692 1701	CHX chips
T24	i 1821 1837	CHX chips before
T25	o 188 227	, microbiologic , and serologic effects
T26	o 440 455	probing depth (
T27	o 471 490	bleeding on probing
T28	o 1132 1141	forsythia
T29	o 1148 1167	Treponema denticola
T30	o 1184 1196	Serum levels
T31	o 1200 1265	high sensitive C-reactive and lipopolysaccharide-binding proteins
T32	o 1301 1311	parameters
T33	o 1417 1437	serologic parameters
T34	o 1512 1550	clinical attachment level ( CAL ) gain
T35	o 1893 1904	subgingival